Ledger.Open graph →

SEC Form D · Amendment · filed October 17, 2016

Castle Creek Pharmaceuticals, LLC

Offering

$48.0M

Sold

$48.0M

Exemption

Rule 506(b)

Industry

Pharmaceuticals

Location

BEDMINSTER, NJ

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Michael Sarkesian · Broomfield, CODirector Joshua Katz · New York, NYDirector Brett Anderson · Broomfield, COExec Fergus Healy · NEW YORK, NYExec Fawaz Al-Mubaraki · NEW YORK, NYExec · Director Jerry Dinges · Broomfield, COExec · Director Michael Shedosky · NEW YORK, NYDirector Russell Valdez · NEW YORK, NYDirector Patrick Morris · BEDMINSTER, NJDirector Timothy Cunniff · BEDMINSTER, NJDirector Kent Roers · Long Lake, MNDirector Susan G. O'Connell · Boston, MADirector Michael Derby · BEDMINSTER, NJExec · Director Antonio Gracias · BEDMINSTER, NJDirector Matthew N. Shea · Boston, MADirector Vincent Campagna · NEW YORK, NYDirector Jeffrey Aronin · BEDMINSTER, NJDirector Greg Licholai · BEDMINSTER, NJExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗